Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response

The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.

Robotic surgery expertise increases odds for those who battle stomach cancer like Toby Keith

Toby Keith, John Wayne and Fred Rogers are among many famous figures who passed from stomach cancer, a particularly deadly form of  cancer. Now, robotic surgery is improving the odds for cancer patients. Matthew Porembka, M.D. is part of a…

Baylor Scott & White Shares Insights At ACG Annual Scientific Meeting 2023

The 2023 American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course will convene in Vancouver, Canada, Oct. 20-25. The ACG is a recognized leader in educating GI professionals and the public about digestive disorders. The ACG’s mission is…